2026-08-25T21:06:41Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/161612024-11-28T12:56:54Zcom_20.500.12105_2398com_20.500.12105_2397com_20.500.12105_2390com_20.500.12105_2336col_20.500.12105_7761

00925njm 22002777a 4500 dc Aguirre-Ghiso, Julio author Dive, Caroline author González Suárez, Eva author Peinado, Héctor author Valiente, Manuel author 2023-11-06 Metastasis is the main driving force for cancer-associated lethality as they are more difficult to treat than primary tumors. The exponential increase in heterogeneity throughout the metastatic cascade and the underlying biology that involves the generation of novel ecosystems incorporating resident and peripheral components of the microenvironment might explain the increased ability to resist therapies. The CNIO Frontier meeting will provide the most up-to-date perspective on metastasis including the best ways to model metastasis, embrace its heterogeneity, prevent metastases from happening, exploit organ-specific survival mechanism of cancer cells among other key topics. These novel research findings will be contributed by leaders in the field, which will make the CNIO Frontier Meeting on Metastasis the most relevant cancer research forum of the year. CNIO-CaixaResearch Frontiers Meeting: Metastasis http://hdl.handle.net/20.500.12105/16161 Metastasis, Innovative Anti-metastasis Therapies, Epigenome, Imaging Metastasis, Modelling Metastasis, Experimental Anti-metastasis Drugs, Metastatic Genome, Metastasis Screens, Microorganismal Influence on Metastasis, CTCs, DTC, ctDNA, Neurobiology of Metastasis CNIO-CaixaResearch Frontiers Meeting: Metastasis